Alignment Healthcare Inc header image

Alignment Healthcare Inc

ALHC

Equity

ISIN US01625V1044 / Valor 110387702

NASDAQ (2025-04-04)
USD 18.11-2.16%

Alignment Healthcare Inc
UMushroom community rating:

star star star star star
5.00 1 votes No rating yet
NegativeNeutralPositive

About company

Alignment Healthcare Inc. is a healthcare company that provides Medicare Advantage plans and related services to seniors in the United States.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (08.01.2025):

Revenue Growth

In the third quarter of 2024, Alignment Healthcare Inc. reported a significant increase in total revenue, reaching $692.4 million. This marks a 51.6% growth compared to the same period in the previous year, showcasing the company's strong financial performance and expansion in the Medicare Advantage market.

Membership Expansion

Alignment Healthcare Inc. experienced a substantial rise in Medicare Advantage membership during the third quarter of 2024. The membership count increased by 57.7% year-over-year, totaling approximately 182,300 members. This growth exceeded both the third-quarter and year-end expectations, highlighting the company's successful member acquisition strategies.

Profitability Metrics

For the third quarter of 2024, Alignment Healthcare Inc. reported an adjusted gross profit of $80.5 million. Despite this positive figure, the company faced a loss from operations amounting to $(19.5) million. The adjusted gross profit excludes certain expenses such as depreciation, amortization, and equity-based compensation.

Adjusted EBITDA and Net Loss

Alignment Healthcare Inc. achieved an adjusted EBITDA of $5.9 million in the third quarter of 2024. However, the company reported a net loss of $(26.4) million for the same period. These figures reflect the company's ongoing investments and operational adjustments to support its growth trajectory.

Future Outlook

Looking ahead, Alignment Healthcare Inc. has raised its year-end health plan membership and revenue guidance for 2024. The company has also narrowed its full-year adjusted gross profit and adjusted EBITDA guidance, indicating a focused approach to achieving its financial targets while continuing to expand its Medicare Advantage offerings.

Summarized from source with an LLMView Source

Key figures

285%1Y
55.5%3Y
%5Y

Performance

69.1%1Y
67.5%3Y
66.9%5Y

Volatility

Market cap

2074 M

Market cap (USD)

Daily traded volume (Shares)

4,682,600

Daily traded volume (Shares)

1 day high/low

11.23 / 10.55

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

5.00

1 votes
Performance:
starstarstarstarstar
5.00
Innovation:
starstarstarstarstar
5.00
Society:
starstarstarstarstar
5.00
Nature:
starstarstarstarstar
5.00
Lina Zapata
Switzerland, 24 Mar 2025
star star star star star
Very good performance during thr challenge

EQUITIES OF THE SAME SECTOR

Jazz Pharmaceuticals PLC
Jazz Pharmaceuticals PLC Jazz Pharmaceuticals PLC Valor: 14769757
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-8.92%USD 110.04
Trupanion Inc
Trupanion Inc Trupanion Inc Valor: 24738737
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.86%USD 34.34
LifeStance Health Group Inc
LifeStance Health Group Inc LifeStance Health Group Inc Valor: 111701745
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.48%USD 6.64
Bausch Health Companies Inc
Bausch Health Companies Inc Bausch Health Companies Inc Valor: 42260834
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.30%USD 5.33
Cooper Companies Inc
Cooper Companies Inc Cooper Companies Inc Valor: 132951296
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.63%USD 73.77
Lifco Ab
Lifco Ab Lifco Ab Valor: 111355378
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.17%SEK 335.80
Inspire Medical Systems Inc
Inspire Medical Systems Inc Inspire Medical Systems Inc Valor: 41329373
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.01%USD 141.93
Evotec SE
Evotec SE Evotec SE Valor: 505433
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.53%EUR 5.51
Dermapharm Holding SE
Dermapharm Holding SE Dermapharm Holding SE Valor: 40166352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.60%EUR 35.55
Elevance Health Inc
Elevance Health Inc Elevance Health Inc Valor: 26124340
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.26%USD 428.89